| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
-mediated Growth Inhibition of Human Breast Cancer Cells1
Department of Medicine/Division of Oncology, University of Texas Health Science Center, San Antonio, Texas 78284-7884
IFN-
-mediated growth inhibition requires signal transducers and
activators of transcription (STAT)-1 activation and may require
induction of the cyclin-dependent kinase inhibitor p21. Using an
electrophoretic mobility shift assay, we identified STAT1 activation
after IFN-
treatment in breast cancer cell lines. Accordingly,
IFN-
inhibited proliferation of monolayer cultured MCF-7 and
MDA-MB-231 breast cancer cells. Interestingly, IFN-
inhibited
anchorage-independent growth of MCF-7 cells but had no effect on
MDA-MB-231colony formation. Because p21 has been shown to play a role
in anchorage-independent growth and is a transcriptional target of
STAT1, we examined the effect of IFN-
on p21 mRNA. We found that
IFN-
induced p21 mRNA in MCF-7 cells but not in MDA-MB-231 cells.
Furthermore, IFN-
induced activation of a p21 promoter-luciferase
reporter construct that contained the STAT1-inducible element in MCF-7
cells, but not in MDA-MB-231 cells. IFN-
treatment resulted in
increased p21 protein in MCF-7 cells, whereas MDA-MB-231 cells did not
appear to express detectable p21, even after IFN-
treatment.
However, in MDA-MB-231 cells, p21 protein was detected only after
proteosome inhibition, suggesting that degradation may be responsible
for the undetectable level of p21 in these cells, despite the abundant
mRNA levels. Finally, focus formation of MDA-MB-231 cells was inhibited
by overexpression of p21. In conclusion, STAT1 activation does not
appear to be sufficient for IFN-
-mediated growth inhibition.
Furthermore, the role of p21 appears to be complex because monolayer
growth inhibition occurs in the absence of p21, but
anchorage-independent growth inhibition may require p21. Breast cancer
cells may provide a unique model for further study of IFN-
signaling.
This article has been cited by other articles:
![]() |
S. Radfar, Y. Wang, and H. T. Khong Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo J. Immunol., November 15, 2009; 183(10): 6800 - 6807. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hiroi, K. Mori, K. Sekine, Y. Sakaeda, J. Shimada, and Y. Ohmori Mechanisms of Resistance to Interferon-{gamma}-mediated Cell Growth Arrest in Human Oral Squamous Carcinoma Cells J. Biol. Chem., September 11, 2009; 284(37): 24869 - 24880. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ding, J.-F. Lee, H. Lu, M.-H. Lee, and D.-H. Yan Interferon-Inducible Protein IFIX{alpha}1 Functions as a Negative Regulator of HDM2. Mol. Cell. Biol., March 1, 2006; 26(5): 1979 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Chatterji, J. E. Riby, T. Taniguchi, E. L. Bjeldanes, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells Carcinogenesis, July 1, 2004; 25(7): 1119 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sironi and T. Ouchi STAT1-induced Apoptosis Is Mediated by Caspases 2, 3, and 7 J. Biol. Chem., February 6, 2004; 279(6): 4066 - 4074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Widschwendter, S. Tonko-Geymayer, T. Welte, G. Daxenbichler, C. Marth, and W. Doppler Prognostic Significance of Signal Transducer and Activator of Transcription 1 Activation in Breast Cancer Clin. Cancer Res., October 1, 2002; 8(10): 3065 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Schroeder, J. Symowicz, and L. A. Schuler PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells Mol. Endocrinol., January 1, 2002; 16(1): 45 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Shin, K. Y. Ahn, H. Kook, J. T. Koh, I. C. Kang, H. C. Lee, and K. K. Kim Overexpressed Human RAD50 Exhibits Cell Death in a p21WAF1/CIP1-dependent Manner: Its Potential Utility in Local Gene Therapy of Tumor Cell Growth Differ., May 1, 2001; 12(5): 243 - 254. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |